Company Profile | February 28, 2014

2014 CRO Leadership Awards Winner

frontage logo

Categories Won:

  1. Quality

  2. Reliability

  3. Productivity

 

Drug Life Cycle Stages:

  • Research & Development: Discovery, Preclinical, Clinical (Phase 1, Phase 2, Phase 3)
  • Drug Substance Production: Primary Process Development, Drug Substance Production
  • Formulated Drug Production: Dosage Form Development, Dosage Form Production

Main Service Areas:
Bioanalytical, Clinical, Preclinical


Services & Capabilities:
Offerings include bioanalysis, preclinical DMPK, clinical and bioequivalence studies, API and product development with analytical support–spanning discovery through late-stage clinical trials. Frontage helps a diverse range of clients with data to support NDA , ANDA , and 505.b.2 submissions.

Therapeutic Areas:
Frontage supports multiple therapeutic areas across different business areas, with expanded expertise in pain management, oncology, and dermatology for small and large molecules.

Song Li, PH. D.

president and CEO

“We are delighted and honored to be recognized by Life Science Leader. More than anything, this recognition is a direct reflection of both our company ethos, and our talented scientists, who bring deep experience, commitment, and scientific curiosity to every project. I believe this combination of qualities reinforces a companywide ability to solve  technical problems and help our clients consistently manage complexity in drug development.”